Attia Najya A, Marzouk Yousef I
Department of Pediatric Endocrinology and Metabolism, King Abdulaziz Medical City, Jeddah 21423, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences, Jeddah 21423, Saudi Arabia.
Case Rep Endocrinol. 2016;2016:6384697. doi: 10.1155/2016/6384697. Epub 2016 Jan 19.
Context. Pseudohypoaldosteronism type 1 (PHA1) is a life-threatening disease that causes severe hyperkalemia and cardiac arrest if not treated appropriately or if diagnosis is missed. Objective. To report a case of a newborn with vomiting and lethargy, ultimately diagnosed with pseudohypoaldosteronism. Patient. This case presented to the ED at an age of 14 days in hypovolemic shock. There was a family history of sudden infant death, her sister who was diagnosed with CAH and passed away at 3 months of age despite regular hormone replacement. Our patient had cardiac arrest in ED, due to hyperkalemia; while receiving fluid boluses, cardiopulmonary resuscitation was initiated. After stabilization, diagnostic workup demonstrated persistently low sodium, acidosis, and high potassium, which required peritoneal dialysis. Based on these findings, the patient was diagnosed with CAH. It turned out later that the patient had PHA1. Two years later, the patient had a new sibling with the same disease diagnosed at birth and started immediately on treatment without any complication. Conclusions and Outcome. This case highlights the significant diagnostic and therapeutic challenges in treating children with PHA1. Adrenal crisis is not always CAH; delayed diagnosis can lead to complication and even death. The presence of high plasma renin activity, aldosterone, and cortisol, along with the presence of hyponatremia and hyperkalemia, established the diagnosis of PHA type 1 and ruled out CAH.
背景。1型假性醛固酮减少症(PHA1)是一种危及生命的疾病,如果治疗不当或漏诊,会导致严重高钾血症和心脏骤停。目的。报告一例以呕吐和嗜睡为表现的新生儿,最终被诊断为假性醛固酮减少症。患者。该病例于14日龄时因低血容量性休克就诊于急诊科。有婴儿猝死家族史,其姐姐被诊断为先天性肾上腺皮质增生症(CAH),尽管定期进行激素替代治疗,但仍在3个月龄时去世。我们的患者在急诊科因高钾血症发生心脏骤停;在给予液体冲击治疗时,开始进行心肺复苏。病情稳定后,诊断性检查显示持续性低钠血症、酸中毒和高钾血症,需要进行腹膜透析。基于这些发现,患者被诊断为CAH。后来发现该患者患有PHA1。两年后,该患者有一个患有相同疾病的新生儿同胞,出生时即被诊断并立即开始治疗,未出现任何并发症。结论与结果。该病例突出了治疗PHA1患儿时面临的重大诊断和治疗挑战。肾上腺危象并不总是CAH;延迟诊断可导致并发症甚至死亡。高血浆肾素活性、醛固酮和皮质醇的存在,以及低钠血症和高钾血症的存在,确立了1型PHA的诊断并排除了CAH。